Resistance to Integrase Inhibitors

被引：83

作者：

Metifiot, Mathieu ^{[1
]}

Marchand, Christophe ^{[1
]}

Maddali, Kasthuraiah ^{[1
]}

Pommier, Yves ^{[1
]}

机构：

[1] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA

来源：

VIRUSES-BASEL | 2010年 / 2卷 / 07期

关键词：

AIDS; HIV-1; integrase; Raltegravir; Elvitegravir; GSK-1349572; GSK-1265744; interfacial inhibitors; resistance; IMMUNODEFICIENCY-VIRUS TYPE-1; TREATMENT-NAIVE PATIENTS; LONG TERMINAL REPEAT; HIV-1; INTEGRASE; STRAND TRANSFER; ACTIVE-SITE; DIKETO ACID; RALTEGRAVIR RESISTANCE; CONCERTED INTEGRATION; RETROVIRAL INTEGRASE;

D O I：

10.3390/v2071347

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Integrase (IN) is a clinically validated target for the treatment of human immunodeficiency virus infections and raltegravir exhibits remarkable clinical activity. The next most advanced IN inhibitor is elvitegravir. However, mutant viruses lead to treatment failure and mutations within the IN coding sequence appear to confer cross-resistance. The characterization of those mutations is critical for the development of second generation IN inhibitors to overcome resistance. This review focuses on IN resistance based on structural and biochemical data, and on the role of the IN flexible loop i.e., between residues G140-G149 in drug action and resistance.

引用

页码：1347 / 1366

页数：20

共 100 条

[1] Role of the 207-218 peptide region of Moloney murine leukemia virus integrase in enzyme catalysis [J].

Acevedo, Monica L. ;

Jaime Arbildua, Jose ;

Monasterio, Octavio ;

Toledo, Hector ;

Leon, Oscar .

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2010, 495 (01) :28-34

[2] Therapeutic Potential of Peptide Motifs Against HIV-1 Reverse Transcriptase and Integrase [J].

Andreola, M. L. .

CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (21) :2508-2519

[3]

[Anonymous], 2009, AIDS Alert, V24, P106

[4] Early Emergence of Raltegravir Resistance Mutations in Patients Receiving HAART Salvage Regimens [J].

Baldanti, Fausto ;

Paolucci, Stefania ;

Gulminetti, Roberto ;

Brandolini, Micaela ;

Barbarini, Giorgio ;

Maserati, Renato .

JOURNAL OF MEDICAL VIROLOGY, 2010, 82 (01) :116-122

[5] Lack of Primary Mutations Associated With Integrase Inhibitors Among HIV-1 Subtypes B, C, and F Circulating in Brazil [J].

Bittencourt-Passaes, Caroline ;

Guimaraes, Monick Lindenmeyer ;

Chequer Fernandez, Saada Lima ;

Lorete, Roberta dos Santos ;

Maia Teixeira, Sylvia Lopes ;

Couto Fernandez, Jose Carlos ;

Morgado, Mariza Goncalves .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 51 (01) :7-12

[6] Genotypic/phenotypic patterns of HIV-1 integrase resistance to raltegravir [J].

Canducci, Filippo ;

Marinozzi, Maria Chiara ;

Sampaolo, Michela ;

Boeri, Enzo ;

Spagnuolo, Vincenzo ;

Gianotti, Nicola ;

Castagna, Antonella ;

Paolucci, Stefania ;

Baldanti, Fausto ;

Lazzarin, Adriano ;

Clementi, Massimo .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (03) :425-433

[7]

Ceccherini-Silberstein F, 2009, AIDS REV, V11, P17

[8] Drug resistance profiles for the HIV integrase gene in patients failing raltegravir salvage therapy [J].

Charpentier, C. ;

Karmochkine, M. ;

Laureillard, D. ;

Tisserand, P. ;

Belec, L. ;

Weiss, L. ;

Si-Mohamed, A. ;

Piketty, C. .

HIV MEDICINE, 2008, 9 (09) :765-770

[9] High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors [J].

Charpentier, Charlotte ;

Laureillard, Didier ;

Piketty, Christophe ;

Tisserand, Pascaline ;

Batisse, Dominique ;

Karmochkine, Marina ;

Si-Mohamed, Ali ;

Weiss, Laurence .

AIDS, 2010, 24 (06) :867-873

[10] Identification of amino acids in HIV-1 and avian sarcoma virus integrase subsites required for specific recognition of the long terminal repeat ends [J].

Chen, AP ;

Weber, IT ;

Harrison, RW ;

Leis, J .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (07) :4173-4182

← 1 2 3 4 5 6 7 8 9 10 →